Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OneRemission is a private New York-based digital health company focused on supporting cancer survivors, patients, and caregivers. Its core product appears to be a mobile app and chatbot platform that delivers integrative oncology content, including guidance on nutrition, exercise, sleep, stress management, and other post-cancer wellness practices. The company is positioned more as a patient-support and survivorship technology provider than as a therapeutic drug developer, and there is no evidence that it operates a traditional biotech or pharma pipeline. Public descriptions also indicate features such as searchable educational content and access to online oncology support. Overall, OneRemission appears to be a commercial-stage oncology digital health company serving the cancer survivorship and supportive-care market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OneRemission.